Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
1,567,774
-
Share change
-
-1,132,141
-
Total reported value
-
$93,015,784
-
Price per share
-
$59.31
-
Number of holders
-
49
-
Value change
-
-$67,109,351
-
Number of buys
-
18
-
Number of sells
-
20
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q4 2017
As of 31 Dec 2017,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,567,774 shares.
The largest 10 holders included
MEITAV DASH INVESTMENTS LTD, GOLDMAN SACHS GROUP INC, CITIGROUP INC, CLS Investments, LLC, UBS Group AG, MORGAN STANLEY, RAYMOND JAMES & ASSOCIATES, BANK OF AMERICA CORP /DE/, Tower Research Capital LLC (TRC), and JANE STREET GROUP, LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.